Cell-Derived Microparticles and Acute Coronary Syndromes: Is there a Predictive Role for Microparticles?

Area of Science:

• Cardiovascular Research
• Biomarker Discovery
• Thrombosis and Hemostasis

Background:

• Acute Coronary Syndromes (ACS) patients face ongoing risks despite treatment advances, with difficult prognosis determination.
• Cell-derived Microparticles (MPs) are linked to atherogenesis and atherothrombosis, suggesting a role in cardiovascular disease.
• Understanding the predictive value of MPs in ACS is crucial for improving patient outcomes.

Purpose of the Study:

• To review existing evidence on the predictive role of Microparticles (MPs) in patients diagnosed with Acute Coronary Syndromes (ACS).
• To synthesize current knowledge regarding various types of MPs and their association with cardiovascular events in ACS.

Main Methods:

• Literature review of experimental and clinical studies.
• Analysis of evidence linking different cell-derived MPs (endothelial, platelet, red blood cell, leukocyte) to ACS prognosis.
• Examination of MPs' association with atherogenesis, atherothrombosis, and angiographic findings.

Main Results:

• Endothelial MPs are associated with future adverse cardiovascular events in ACS patients.
• The predictive role of platelet-derived MPs remains debated, despite their pro-coagulant effects.
• Red blood cell-derived MPs may indicate ongoing thrombosis in ACS, contrasting with their anti-coagulant properties in healthy individuals.
• Leukocyte-derived MPs show potential predictive value, though research is limited.
• Circulating MPs may offer insights into the severity of angiographic lesions in ACS.

Conclusions:

• Microparticles (MPs) represent a promising class of circulating biomarkers for Acute Coronary Syndromes (ACS).
• Large-scale clinical studies are necessary to validate the clinical significance of plasma MP measurement.
• Quantifying MP levels could potentially inform more aggressive treatment strategies for high-risk ACS patients.